Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan
Department of Intensive Care, Chiba Emergency Medical Center, Chiba, Japan.
BMJ Open. 2022 Apr 1;12(4):e053743. doi: 10.1136/bmjopen-2021-053743.
Resuscitative endovascular balloon occlusion of the aorta (REBOA) has been used as a bridge to definitive bleeding control of subdiaphragmatic injury. Since previous observational studies have poorly adjusted for confounding factors, it is necessary to incorporate REBOA-specific and time-varying covariates in the model. We hypothesised that REBOA improves the survival of haemodynamically unstable torso trauma patients after comparing the REBOA group with a matched control group (non-REBOA group).
The Japanese Association for the Surgery of Trauma-REBOA Study is a prospective, multicentre, matched cohort study organised by the Clinical Trial Committee of the Japanese Association for the Surgery of Trauma. To minimise observational study biases, this study will prospectively register traumatic shock patients who require bleeding control within 60 min upon arrival at the emergency department, with in-hospital mortality as the primary outcome. After the data set is fixed, the missing values for all variables will be imputed using the multiple imputation technique. In the primary analysis, propensity scores for the probability of REBOA decision (regardless of the actual REBOA deployment) will be calculated from the baseline information using a logistic regression generalised linear mixed-effects model, which will be performed for both the REBOA use and non-REBOA use groups.
This study was approved by the ethics committee of each participating hospital. The results will be disseminated to the participating hospitals, submitted to peer-reviewed journals for publication and presented at congresses.
UMIN Clinical Trials Registry (UMIN000035458).
主动脉球囊阻断复苏(REBOA)已被用作通往明确控制膈肌下损伤的出血的桥梁。由于之前的观察性研究对混杂因素的调整较差,因此有必要在模型中纳入特定于 REBOA 和随时间变化的协变量。我们假设 REBOA 通过比较 REBOA 组和匹配对照组(非 REBOA 组)来改善血流动力学不稳定的躯干创伤患者的存活率。
日本创伤外科学会-REBOA 研究是一项由日本创伤外科学会临床试验委员会组织的前瞻性、多中心、匹配队列研究。为了最大程度地减少观察性研究偏倚,本研究将前瞻性地登记需要在急诊科到达后 60 分钟内进行出血控制的创伤性休克患者,以院内死亡率为主要结局。数据集固定后,将使用多重插补技术对所有变量的缺失值进行插补。在主要分析中,将使用逻辑回归广义线性混合效应模型从基线信息中计算出用于 REBOA 决策(无论实际是否部署 REBOA)的概率的倾向评分,这将在 REBOA 使用和非 REBOA 使用组中进行。
本研究已获得各参与医院伦理委员会的批准。研究结果将传播给参与医院,提交给同行评议期刊发表,并在大会上展示。
UMIN 临床研究注册(UMIN000035458)。